Summary: In order to help molecular geneticists to rapidly identify CNVs responsible for inherited diseases among amplicons sequencing data generated by NGS, we designed a user-friendly tool 'Cov'Cop'. Using the run's coverage file provided by the sequencer, Cov'Cop simultaneously analyzes all the patients of the run using a two-stage algorithm containing correction and normalization levels and provides an easily understandable output, showing with various colors, potentially deleted and duplicated amplicons. Availability and Implementation: https://git.unilim.fr/merilp02/CovCop
Introduction
Next Generation Sequencing is a revolution in the diagnosis of diseases presenting a broad genetic heterogeneity, because all of the genes involved in a complex disease can be tested at the same time for one or several patients. Two main approaches can be used: a capture strategy or one based on gene amplification, both of them being able to detect single-nucleotide-polymorphisms (SNPs) efficiently. However, while several tools exist to detect CopyNumber-Variations (CNVs) with capture strategy, no suitable tool was available to detect CNVs in inherited diseases studied with amplicon sequencing. Thus we developed Cov'Cop, a user-friendly tool able to detect duplication or deletion events using the raw-readcount (RRC) value of each amplicon (provided as a coverage file for each run by the sequencer). It is based on the fact that in common cases, the two alleles have to be similarly amplified within each amplicon. Several normalization steps, guided by carefully chosen references amplicons, permit to compute a score for each amplicon. Theoretical score of 1 is the normal case while low (<0.5) or high (>1.5) values respectively reveal deletions or duplications.
Materials and methods
To detect CNVs among sequencing data generated by amplicon sequencing, Cov'Cop compares the RRC of one patient to those of the other patients of the same run. A two-stage algorithm is applied to the whole untreated RRC matrix (M RRC ). Correction stage. For each patient, we correct the value of each amplicon's RRC by the total of all the amplicons of the prepared library (in order to compare one patient to the other ones correctly). We also correct the RRC according to amplicons' GC rate and length, which influence amplification efficiency (Benjamini and Speed, 2012; Dillies et al., 2013) . This correction step leads to M CRC , the corrected-read-count (CRC) matrix. 
Dataset
Every amplified dataset can be used on Cov'Cop (see Supplementary Data N 1: Data Set).
Input files
The tool first needs a file describing the amplification design. Each line of this file describes an amplicon using seven characteristics displayed in seven columns: pool, chromosome, start position, end position, amplicon ID, gene name and sequence. The second input file is directly provided by the sequencer. The first column shows the amplicon ID, the second column the gene name linked to this amplicon and the next ones the RRC for each amplicon (one column corresponding to one patient). We simply create M RRC from this file keeping patients in columns and corresponding amplicons' RRC in lines:
Thus, in M RRC , the RRC corresponding to the amplicon i belonging to patient j is simply noted RRC A_i_P_j .
Correction stage
Before starting this correction stage, a quality control can be performed by overviewing each patient amplification (Supplementary Data N 2). A succession of corrections is then performed patient by patient, in order to make them comparable within each run. Multiplex PCR is usually performed using two or more tubes (named pool). Each correction is therefore performed for each pool independently.
• Correction by the size of the library: As a first correction step, we choose (for each patient) to scale all his RRC values by the total number of reads of the patient's library. We start the construction of M CRC in the following way:
• Correcting the GC-content and the amplicon length bias: To correct the known GC-content bias we group each amplicon by GC rate (range of 0.1). Then, inside each of these groups, we normalize all CRC A_i_P_j cells by the group median (see Supplementary Data N 3).
Similarly, the known amplicon length bias is corrected exactly the same way as due to GC-content except that the amplicons are classified according to their length of sequences by range of 10 pb (see Supplementary Data N 4).
• Gender correction: see Supplementary Data N 5
Normalization/analysis stage
• Normalization by Reference Amplicons: This stage is based on the semi-quantitative RT-PCR normalization method using a reference gene. In order to choose reference amplicons (amplified the same way in all the patients of one run), we need, using M CRC as an input, to compute M A_i and V A_i , respectively the median and the variance of each amplicon i among all the patients. We also compute M run the median of all the M A_i values. We choose to tag as Reference Amplicons:
• Amplicons exhibiting a minimum variance value V A_i • Amplicons having a M A_i value that varies in a 620% range around M run We found (see Supplementary Data) that the best normalization was obtained using a minimum of 10% of all of our amplicons as references. For each patient j, the median value Mref_P_j of the selected Reference Amplicons CRC is computed and then each cell of the column j in the matrix MCRC is normalized by Mref_P_j.
• Ratio between patients: This last step leads to the final matrix M CRC by bringing the CRC A_i_P_j values equal to 1 for a gene present in two copies, to 0.5 for a deletion event and to 1.5 for duplication. Each cell of the line i in the matrix M CRC is then normalized by M A_i .
Results
Cov'Cop was tested on several coverage files obtained by Proton or PGM sequencing. It allows to easily detect indels. Figure 1 shows an overview of Cov'Cop from the initial matrix to the final normalized one where we can see the duplicated amplicons of PMP22 over-lined in red for patient 62 and the deletion of PMP22 over-lined in orange for patient 64 by Cov'Cop. We estimated Cov'Cop sensitivity between 80 and 90% and the specificity around 98% (see Supplementary Data N 6).
Conclusions
Cov'Cop is written in Java. It can easily be run on different operating systems. It has been designed with an intuitive GUI ( Fig. 1) that enables to analyze results in real-time as well as to handle user preferences and control thresholds (see Supplementary Data N 7). For these reasons, we believe it could be of some help to molecular geneticists to rapidly identify indels.
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